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Abstract 
Objective: The aim of this study was to assess the rate of glycemic control and factors affecting glycemic control in 
type 2 diabetic patients.
Results: A total of 174 type 2 diabetic patients were interviewed and were studied. Mean age of the patients was 
48.98 ± 14.96 years (range 18–80 years). More than half (51.7%) of the patients were males. About a third of patients, 
53 (30.5%), were on antidiabetic medications for less than 5 years. The most common prescribed antidiabetic medica-
tions were insulin, 48 (27.6%), and metformin 15 (8.6%). One hundred seven (61.5%) patients were on combination 
therapy (two drug treatment) and the remaining patients were on monotherapy. The majority, 103 (59.2%), of patients 
had uncontrolled blood glucose. A larger proportion of female patients, 54 (52.4%), had uncontrolled blood glucose 
than males. Level of education (p < 0.001) and duration of diabetes treatment (p < 0.001) were significantly associ-
ated with glycemic control. Adherence of patients to regular follow up (Adjusted Odds Ratio (AOR) = 2.42, 95% CI 
1.08–5.44, p = 0.03) and diabetes treatment for 5–10 years (AOR = 4.64, 95% CI 1.79–12.06, p = 0.002) are found to be 
independent predictors of glycemic control among type 2 diabetes patients.
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Introduction
Diabetes mellitus (DM) is a metabolic disorder that may 
be caused by multiple etiologies. It is characterized by 
chronic hyperglycemia due to defects in insulin secretion, 
insulin action, or both [1]. There are four types of diabe-
tes mellitus: type 1 diabetes, type 2 diabetes, gestational 
diabetes, and other specific types [2].
Type 2 diabetes constitutes about 85–95% of all dia-
betes in high-income countries with a higher percent-
age in low- and middle-income countries due to rapid 
socio-cultural changes, ageing populations, increasing 
urbanization, reduced physical activity and unhealthy 
lifestyle and behavioral patterns [2, 3]. It is a leading 
cause of blindness, end stage renal disease and stroke. 
These complications are two to five times more common 
among diabetic patients [4]. Type 2 diabetes is associated 
with increased morbidity and mortality compared with 
the general population [5]. About 80% of diabetes deaths 
occur in low and middle income countries [6].
Evidence shows that the main therapeutic goal for all 
diabetes patients is maintaining good glycemic control 
so as to prevent organ damage and micro-vascular and 
macro-vascular complications. However, the majority 
of patients fail to achieve good glycemic control and the 
reasons for poor glycemic control are complex and multi 
factorial [7, 8]. Patients with poor glycemic control may 
experience many symptoms of diabetes, possible cog-
nitive impairment, immune dysfunction, and hospital 
admissions and complications [6, 9].
In Ethiopia, the prevalence of diabetes admission has 
increased from 1.9% in 1970 to 9.5% in 1999 of all medi-
cal admissions [10] most importantly uncontrolled blood 
glucose due to non-compliance to antidiabetic medica-
tions [11]. As to the authors’ knowledge, studies on the 
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rate of glycemic control in type 2 diabetes patients in 
Southwest Ethiopia are limited. The aim of this study was 
to assess the rate of glycemic control and factors affecting 
glycemic control in type 2 diabetic patients on follow-up 
at Shanan Gibe Hospital, Southwest Ethiopia.
Main text
Research methods and patients
A cross sectional study was conducted at Shanan Gibe 
Hospital from February to March, 2016. Shanan Gibe 
Hospital is a public hospital which serves both inpatients 
and out patients. It is located in Jimma Zone, Oromia 
region, Southwest Ethiopia. Diabetic patients get follow 
up service from the hospital twice a week.
Jimma University Institutional Review Board approved 
the research. We received a letter of permission to access 
data from clinical director of the hospital. To collect for 
demographic data, we obtained written informed con-
sent of the study participants prior to interviews. The 
right of participants to withdraw from an interview at 
any time was maintained. We determined sample size 
using single population proportion formula. We studied 
all type 2 diabetes patients who fulfilled the inclusion cri-
teria and visited the diabetes clinic of the hospital during 
the study period. The main outcome of the study was gly-
cemic control. We trained data collectors to maintain the 
quality of the data. We translated an English version of 
the questionnaire to local language and back translated to 
English. The data collection tool was also pretested.
We included participants in the study with type 2 dia-
betes and ≥  18  years old, patients who were on anti-
diabetic medication(s) treatment for at least 6  months, 
patients with at least three consecutive blood glucose 
measurements for 3 months, and patients who consented 
to participate. Patients with hearing problems and previ-
ously diagnosed psychiatric illness were excluded from 
the study. Data were collected by two trained pharma-
cists. We used a pretested structured questionnaire to 
collect data about sociodemographic characteristic. Data 
abstraction format was used to collect data on clinical 
characteristics of patients such as diagnosis, duration of 
illness, dosage regimen of medications, comorbidities, 
diabetes complications, and blood glucose measure-
ments. A structured questionnaire was used to collect 
patients’ demographics.
Statistical analysis
We analyzed the data using SPSS Version 21.0 (Chicago, 
SPSS Inc.). We used Chi square tests to see the associa-
tion between categorical variables and level of blood glu-
cose control. To examine factors affecting medication 
adherence, we performed a multivariate logistic regres-
sion analysis. Variables with p  <  0.25 on a univariate 
logistic regression analysis were entered into a multi-
variate logistic regression analysis model to identify inde-
pendent factors that affect glycemic control. Variables 
with p  <  0.05 were considered statistically significant 
with 95% level of confidence.
Operational definitions and definition of terms
Controlled blood glucose was defined as average fasting 
blood glucose measurement 80–130 mg/dL [12]. Uncon-
trolled blood glucose was defined as patients whose aver-
age blood glucose measurements on three consecutive 
visits is > 130 or < 70 mg/dL. Family adherence support 
was defined if patients get any kind of support and/or 
advice from their family member related to medication 
(s) and life style conditions.
Results
Baseline characteristics of patients
We studied 174 patients who visited the hospital dur-
ing the study period. More than half, 90 (51.7%), of 
the patients were males. Mean age of the patients was 
49.98 ± 14.9 years (range 18–80 years). More than a third 
of the patients, 74 (42.5%), attended primary school. Sev-
enty-four (42.5%) patients did not adhere to their regular 
follow up at the diabetes clinic of the hospital. The major-
ity of patients, 111 (63.8%), did not get adherence support 
from their families (Table  1). About a third of patients, 
53 (30.5%), were on antidiabetic medications for less 
than 5  years. Almost half of the patients were on treat-
ment for more than 10 years 86 (49.4%). Ninety (51.7%) 
patients had at least one co-morbidity. Hypertension was 
the major type of co-morbidity; 71 (78.9%). Seventy-one 
(40.8%) of the patients had ≥ 1 diabetes related complica-
tion. Diabetic neuropathy was the most common compli-
cation; 31 (43.7%).
The most common prescribed antidiabetic medication 
was insulin, 48 (27.6%) followed by metformin 15 (8.6%). 
More than half; 92 (52.9%) of the patients were taking a 
combination of metformin and glibenclamide (Table  2). 
One hundred seven (61.5%) of patients were on combi-
nation therapy (two drug treatment) and the remain-
ing patients were on monotherapy. Sixty-two (35.6%) 
patients had concomitant medication(s) for the treat-
ment of comorbidities. Enalapril was the most common 
prescribed concomitant medication; 47 (75.8%).
Glycemic control and factors affecting glycemic control
Fasting blood glucose readings of last three clinic visits 
were obtained from patients’ medical records and the 
mean last three fasting blood glucose measurements 
were used to determine the level of glycemic control. 
Mean fasting blood glucose measured over 3  months 
was 130.3 ±  30.7  mg/dL. The minimum and maximum 
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recorded fasting blood glucose measurements were 33 
and 254  mg/dL respectively. Less than half, 71 (40.8%), 
of the patients achieved the American Diabetes Asso-
ciation recommended target fasting blood glucose range 
(80–130 mg/dL). The majority, 103 (59.2), of patients had 
uncontrolled blood glucose. The rate of glycemic control 
was 71 (40.8%).
A larger proportion of female patients, 54 (52.4%), had 
uncontrolled blood glucose than males. Level of education 
(p < 0.001) and duration of diabetes treatment (p < 0.001) 
were significantly associated with glycemic control.
On a multivariable logistic regression analysis (Table 3), 
adherence of patients to regular follow up (adjusted odds 
ratio (AOR)  =  2.42, 95% CI 1.08–5.44, p  =  0.03) and 
diabetes treatment for 5–10 years (AOR = 4.64, 95% CI 
1.79–12.06, p  =  0.002) were found to be independent 
predictors of glycemic control among type 2 diabetes 
patients at Shanan Gibe Hospital.
Discussion
This study assessed the magnitude of glycemic control 
and factors affecting glycemic control among type 2 dia-
betic patients at Shanan Gibe Hospital, Southwest Ethio-
pia. The mean fasting blood glucose was 130.3 ± 30.7 mg/
dL. We found that the majority of patients had poor gly-
cemic control. Adherences to regular follow up schedule 
and diabetes treatment for 5–10 years were predictors of 
glycemic control.
Table 1 Characteristics of type 2 diabetes patients at Shanan Gibe Hospital, Southwest Ethiopia
Others dyslipidemia and obesity
CKD chronic kidney disease, IHD Ischemic heart disease
Variable category Characteristics n (%)
Sex Male 90 (51.7)
Female 84 (48.3)
Age category < 30 21 (12.1)
30–60 114 (65.5)
> 60 39 (22.4)
Level of educational Illiterate 60 (34.5)
Primary education 74 (42.5)
Secondary education 35 (20.1)
College and above 5 (2.9)
Marital status Single 14 (8.0)
Married 142 (81.6)
Divorced/separated 18 (10.3)
Regular follow up No 74 (42.5)
Yes 100 (57.5)
Family support Yes 63 (36.2)
No 111 (63.8)
Duration of diabetes treatment (years) < 5 53 (30.5)
5–10 35 (20.1)
> 10 86 (49.4)
Co-morbidity Yes 90 (51.7)
No 84 (48.3)
Type of co-morbidity Hypertension 71 (78.9)
Ischemic heart disease (IHD) 10 (11.1)
Hypertension + IHD 5 (5.6)
CKD 2 (2.2)
Others 2 (2.2)
Diabetic complications Yes 71 (40.8)
No 103 (59.2)
Type of diabetic complication Neuropathy 31 (43.7)
Retinopathy 10 (14.1)
Retinopathy + Neuropathy 28 (39.4)
Retinopthy + Neuropathy + Nephropathy 2 (2.8)
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In our study, the mean fasting blood glucose over 
3  months was 130.3 ±  30.7  mg/dL. This value is lower 
than the study in Malaysia [13] where the mean fasting 
blood glucose was 166.5 ± 86.4 mg/dL. It was also higher 
than the studies in Addis Ababa (190 ± 89.6 mg/dL) [14] 
and Jimma university specialized hospital (171 ± 63 mg/
dL) [15], and higher than the American Diabetic Asso-
ciation recommendation [12]. This higher value indi-
cates that the rate of blood glucose in our setup is poor 
and does not meet the recommended target of the 
American Diabetes Association. This may be due to poor 
medication adherence, poor lifestyle conditions and, fail-
ure to adhere to regular follow up at diabetes clinic.
We found that the majority of our patients (59.2%) had 
uncontrolled blood glucose. The rate of uncontrolled 
blood glucose in our study finding is lower than the find-
ings in Jordan [16], Malaysia [13] and India [17] ranging 
from 65.1 to 78.6%. In our study, we measured fasting 
blood glucose to assess glycemic control whereas in the 
for stated studies, glycated hemoglobin (HbA1C) was 
measured to assess the level of glycemic control.
The reason for the difference in the rate of glycemic 
control between our study and other studies may be 
the variation in clinical characteristics of the partici-
pants. For example, in Malay study, the participants were 
older than ours and the patients with duration of diabe-
tes < 5 years in ours was 30.5% whereas in Malay it was 
24.2%. In Jordan, about 50% of the patients had diabetes 
duration > 7 years and the majority of patients had obe-
sity, dyslipidemia and hypertension. In addition, in Indian 
study, larger proportion of patients were > 50 years old. 
Evidence also shows that longer duration of diabetes, use 
of multiple medications, and old age are associated with 
poorly controlled blood glucose [13, 16, 18, 19].
Other studies in Ethiopia showed that the rate of 
uncontrolled blood glucose ranged from 48.7% based on 
HBA1C measurement to 70.9% on fasting blood glucose 
measurement [20, 21]. This is comparable to our study 
finding with a slightly higher value (70.9%) in only one 
study. The similarity of our study finding with other local 
studies may be due to similar characteristics of the study 
patients and similar diabetes management practice.
The rate of uncontrolled blood glucose in our study 
finding was higher than the study findings in Nigeria [22], 
Table 2 Type of antidiabetic medications of type 2 dia-
betic patients attending the diabetic clinic of Shaman Gibe 
hospital
Others include metoprolol, amlodipine and atorvastatin
ASA acetyl salicylic acid
Variable category Type of antidiabetic medi-
cation
n (%)





Insulin + metformin 15 (8.6)
Metformin + glibenclamide 92 (52.9)
Concomitant medications Yes 62 (35.6)
No 112 (64.4)
Type of concomitant medica-
tion
Enalapril 47 (75.8)
Enalapril + ASA + atenolol 6 (9.7)
Enalapril + ASA 3 (4.8)




Table 3 Factors associated with glycemic control of type 2 diabetes patients at Shanan Gibe Hospital, Southwest Ethiopia
AOR adjusted odds ratio
p < 0.05 was considered statistically significant
* Statistically significant
Variable category Glycemic control AOR (95% CI)
Controlled (n) Uncontrolled (n)
Gender Male 41 49 1.58 (0.79–3.15)
Female 34 54 1
Educational status Illiterate 10 50 1
Primary school 39 35 2.20 (0.81–5.97)
Secondary school 19 16 2.31 (0.71–7.52)
College and above 3 2 1.79 (0.20–15.86)
Regular follow up No 17 57 1
Yes 54 46 2.42 (1.08–5.44)*
Duration of treatment (years) < 5 28 25 2.03 (0.85–4.84)
5–10 23 12 4.64 (1.79–12.06)*
> 10 20 66 1
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China [23], Brazil [24], Mexico [25] and the United States 
[26]. Level of uncontrolled blood glucose in these coun-
tries ranged from 12.9 to 57%. This variation could be due 
to differences in patient characteristics and differences 
in diabetes management practices. For example, in our 
study, the rate of illiteracy was high and regular follow up 
of diabetes patients was minimal. In addition, appropriate 
diabetes management guideline was used in other studies 
while no diabetes management guideline was used in the 
management of type 2 diabetes in our hospital. Moreover, 
fasting blood glucose was measured to assess the level of 
glycemic control in our setup while glycated hemoglobin 
was used in the studies we compared.
In our study, the number of illiterate patients with 
uncontrolled blood glucose was high and about half 
(48.3%) of them had uncontrolled blood glucose. Educa-
tion level was also significantly associated with glycemic 
control in our study. The possible explanation could be 
illiterate patients may have low diabetes knowledge, low 
self-management behaviors, lower self-efficacy and lower 
continuity of care leading to poor glycemic control. How-
ever, in contrast to our study finding, in the United King-
dom, patients with lower level of educational had better 
compliance to medications and more trust in the physi-
cians’ advice [27].
The duration of diabetes mellitus was significantly 
associated with glycemic control. A study in Hong Kong 
[26] revealed that patients with longer duration of diabe-
tes and more complex treatment regimens were associ-
ated with poorer glycemic control. Juarez et al. [28] also 
reported that patients who had had diabetes for 10 years 
were about nine times more likely to have poor glycemic 
control than those who had had diabetes for 3  years. A 
longer duration of diabetes negatively affects glycemic 
control, possibly because of progressive impairment 
of insulin secretion over time as a result of β‐cell fail-
ure. Therefore, as the disease progresses, most patients 
require an increase in their pharmacotherapy to maintain 
glycemic control.
Adherence of patients to regular follow up and diabe-
tes treatment for 5–10 years were found to be independ-
ent predictors of glycemic control among type 2 diabetes 
patients. This study finding is similar to other studies 
[13, 18, 19]. Viana et al. [29] and Ramirez et al. [25] also 
reported that duration of diabetes, use of insulin, and 
unsatisfactory patient physician relationship were signifi-
cantly associated with level of glycemic control.
Conclusion
In conclusion, our study finding showed that the rate of 
poor glycemic control was high. Level of education and 
duration of diabetes treatment were significantly associ-
ated with glycemic control. A longer duration of diabetes 
and lack of regular follow up at diabetes clinic indepen-
dently affect the rate of glycemic control in type 2 diabe-
tes patients. Therefore, we recommend that Shanan Gibe 
Hospital develop strategies for improving glycemic con-
trol of type 2 diabetes patients.
Limitations
The study has some limitations.
  • The sample size was relatively small which may limit 
generalization of the study findings to a larger popu-
lation of type 2 diabetes patients.
  • We used fasting blood glucose to assess level of gly-
cemic control as there was no laboratory facility to 
measure glycated hemoglobin. Measurement of gly-
cated hemoglobin would show the rate of glycemic 
control over 3 months while fasting blood sugar may 
have some drawbacks to show the true level of glyce-
mic control.
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